http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc#head http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc http://www.nanopub.org/nschema#hasAssertion http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc#assertion http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc http://www.nanopub.org/nschema#hasProvenance http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc#provenance http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc http://www.nanopub.org/nschema#hasPublicationInfo http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc#publicationInfo http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc#assertion http://rdf.disgenet.org/resource/gda/DGN5db8bf3b008f275f6b7b5f55f5971351 http://semanticscience.org/resource/SIO_000628 http://identifiers.org/ncbigene/142 http://rdf.disgenet.org/resource/gda/DGN5db8bf3b008f275f6b7b5f55f5971351 http://semanticscience.org/resource/SIO_000628 http://linkedlifedata.com/resource/umls/id/C0029925 http://rdf.disgenet.org/resource/gda/DGN5db8bf3b008f275f6b7b5f55f5971351 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://semanticscience.org/resource/SIO_001123 http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc#provenance http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc#assertion http://purl.org/dc/terms/description [In this study, we examined the respective roles of the ATR and Chk1 kinases in ovarian cancer cells using genetic and pharmacologic inhibitors in combination with cisplatin, topotecan, gemcitabine, and the PARP inhibitor veliparib (ABT-888), four agents with clinical activity in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine. http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc#assertion http://purl.org/ontology/wi/core#evidence http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc#assertion http://semanticscience.org/resource/SIO_000772 http://identifiers.org/pubmed/23548269 http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://rdf.disgenet.org/v5.0.0/void/BEFREE http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc#assertion http://www.w3.org/ns/prov#wasGeneratedBy http://purl.obolibrary.org/obo/ECO_0000203 http://rdf.disgenet.org/v5.0.0/void/BEFREE http://purl.org/pav/importedOn 2017-02-19 http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://purl.obolibrary.org/obo/ECO_0000212 http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/2000/01/rdf-schema#comment Gene-disease associations inferred from text-mining the literature. http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/2000/01/rdf-schema#label DisGeNET evidence - LITERATURE http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc#publicationInfo http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc http://purl.org/dc/terms/created 2017-10-17T13:10:17+02:00 http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc http://purl.org/dc/terms/rights http://opendatacommons.org/licenses/odbl/1.0/ http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc http://purl.org/dc/terms/rightsHolder http://rdf.disgenet.org/v5.0.0/void/IBIGroup http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc http://purl.org/dc/terms/subject http://semanticscience.org/resource/SIO_000983 http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc http://purl.org/net/provenance/ns#usedData http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc http://purl.org/pav/authoredBy http://orcid.org/0000-0001-5999-6269 http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc http://purl.org/pav/authoredBy http://orcid.org/0000-0002-7534-7661 http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc http://purl.org/pav/authoredBy http://orcid.org/0000-0002-9383-528X http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc http://purl.org/pav/authoredBy http://orcid.org/0000-0003-0169-8159 http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc http://purl.org/pav/authoredBy http://orcid.org/0000-0003-1244-7654 http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc http://purl.org/pav/createdBy http://orcid.org/0000-0003-0169-8159 http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc http://purl.org/pav/version v5.0.0.0 http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf http://purl.org/pav/version v5.0.0